| 261 |
Albumin-Based Nanoparticles as Magnetic Resonance Contrast Agents: I. Concept, First Syntheses and Characterisation |
2010 |
| 262 |
Albumin-based Nanoparticles as Magnetic Resonance Contrast Agents: II. Physico-chemical Characterisation of Purified and Standardised Nanoparticles |
2010 |
| 263 |
Synthesis of New 4,5-3(2H)pyridazinone Derivatives and their
Cardiotonic, Hypotensive, and Platelet Aggregation Inhibition
Activities |
2010 |
| 264 |
Synthesis of New 4,5-3(2H)pyridazinone Derivatives and their
Cardiotonic, Hypotensive, and Platelet Aggregation Inhibition
Activities |
2010 |
| 265 |
Potent Small Molecule murine CD22-Inhibitors: Exploring the Interaction of the residue at C-2 of Sialic Acid Scaffold |
2009 |
| 266 |
Slit2–Robo4 Signalling Promotes Vascular Stability by
Blocking Arf6 Activity |
2009 |
| 267 |
Synthesis and Potential Biological Activities of Certain New
Substituted Thiazoline-Quinoline Derivatives |
2009 |
| 268 |
Synthesis and Potential Biological Activities of Certain New
Substituted Thiazoline-Quinoline Derivatives |
2009 |
| 269 |
Synthesis and Potential Biological Activities of Certain New
Substituted Thiazoline-Quinoline Derivatives |
2009 |
| 270 |
Synthesis of biotinylated sialosides to probe CD22-ligand interactions |
2009 |
